---
layout: post
title: USAN Watch - September 2010
date: '2010-09-16T16:26:00.023+01:00'
author: John Overington
tags:
- INNS and USANS
modified_time: '2010-12-23T09:59:18.214Z'
thumbnail: http://1.bp.blogspot.com/_SlPG9DIz_AA/TRMdAwQ9plI/AAAAAAAAA9o/JWhTN1q3_NQ/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-6562117858595249789
blogger_orig_url: http://chembl.blogspot.com/2010/09/usan-watch-september-2010.html
---

<div class="separator" style="clear: both; text-align: center;"><a href="http://1.bp.blogspot.com/_SlPG9DIz_AA/TRMdAwQ9plI/AAAAAAAAA9o/JWhTN1q3_NQ/s1600/inns+and+usans.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://1.bp.blogspot.com/_SlPG9DIz_AA/TRMdAwQ9plI/AAAAAAAAA9o/JWhTN1q3_NQ/s1600/inns+and+usans.png" /></a></div><center><br />
</center><center>  </center>    The September 2010 USANs have just been published, these are:<br />
<div><br />
<div><br />
<center>  <table width=100% border="1"><tbody>
<tr><td>algenpantucel-L  </td><td></td><td>Whole cell immunotherapy </td><td>therapeutic </td><td>n/a</td></tr>
<tr><td>amatuximab </td><td>MORAb-009 </td><td>monoclonal antibody </td><td>therapeutic </td><td>mesothelin</td></tr>
<tr><td>arbaclofen </td><td>STX-209</td><td>small molecule </td><td>therapeutic </td><td>GABA B receptor</td></tr>
<tr><td>atopaxar </td><td>ER-172594-00, E-5555 </td><td>small molecule </td><td>therapeutic </td><td>PAR-1</td></tr>
<tr><td>atopaxar hydrobromide </td><td>E-5555, ER-172594-06 </td><td>small molecule </td><td>therapeutic </td><td>PAR-1</td></tr>
<tr><td>avagacestat </td><td>BMS-708163-01 </td><td>small molecule </td><td>therapeutic </td><td>gamma-secretase</td></tr>
<tr><td>carlumab </td><td>CNT0-888 </td><td>monoclonal antibody </td><td>therapeutic </td><td>MCP-1</td></tr>
<tr><td>danoprevir sodium </td><td>RO-5190591-001, R-7227, ITMN-191  </td><td>small molecule</td><td>therapeutic </td><td>HCV NS3 proteinase</td></tr>
<tr><td>edivoxetine </td><td>LY-2216684 </td><td>small molecule </td><td>therapeutic </td><td>NET</td></tr>
<tr><td>enavatuzumab </td><td>PDL-192 </td><td>monoclonal antibody </td><td>therapeutic </td><td>CD266</td></tr>
<tr><td>erteberel </td><td>LY-500307 </td><td>small molecule </td><td>therapeutic </td><td></td></tr>
<tr><td>fulranumab </td><td>JNJ-42160443, AMG-403 </td><td>monoclonal antibody </td><td>therapeutic </td><td>beta-NGF</td></tr>
<tr><td>icrucumab </td><td>IMC-18F1 </td><td>monoclonal antibody </td><td>therapeutic </td><td>FLT-1</td></tr>
<tr><td>levoglucose </td><td>FM-602 </td><td>sugar  </td><td></td><td>n/a</td></tr>
<tr><td>linsitinib </td><td>OSI-906 </td><td>small molecule </td><td>therapeutic </td><td>IGF1R</td></tr>
<tr><td>mogamulizumab </td><td>KW-0761, KM-8761 </td><td>monoclonal antibody </td><td>therapeutic </td><td>CCR4</td></tr>
<tr><td>pegsiticase </td><td>Uricase-PEG 20 </td><td>enzyme </td><td>therapeutic </td><td>n/a</td></tr>
<tr><td>plecanatide </td><td>SP-304 </td><td>peptide </td><td>therapeutic </td><td>Guanylyl cyclase receptor-C</td></tr>
<tr><td>ponatinib </td><td>AP-24534 </td><td>small molecule </td><td>therapeutic </td><td>ABL1 FLT3 VEGFR FGFR TIE2 </td></tr>
<tr><td>ponatinib hydrochloride </td><td>AP-24534 </td><td>small molecule </td><td>therapeutic </td><td>ABL1 FLT3 VEGFR FGFR TIE2 </td></tr>
<tr><td>quizartinib </td><td>AC-220, AC-010220 </td><td>small molecule </td><td>therapeutic </td><td>KIT CSF1R FLT3 PDGFRa PDGFRb RET </td></tr>
<tr><td>quizartinib dihydrochloride </td><td>AC-220, AC-010220</td><td>small molecule </td><td>therapeutic</td><td>KIT CSF1R FLT3 PDGFRa PDGFRb RET</td></tr>
<tr><td>solithromycin </td><td>CEM-101, OP-1068 </td><td>natural product </td><td>therapeutic </td><td>50S Ribosomal Protein</td></tr>
<tr><td>simenepag </td><td>AGN-210676 </td><td>small molecule </td><td>therapeutic </td><td>Non-Prostanoid Prostaglandin receptor</td></tr>
<tr><td>talminogene laherparepvec </td><td>JS1 34.5-hGMCSF 47- pA- </td><td>virus </td><td>therapeutic</td><td>n/a</td></tr>
<tr><td>tofogliflozin </td><td>CSG-452 </td><td>small molecule </td><td>therapeutic </td><td>SGLT2</td></tr>
<tr><td>urelumab </td><td>BMS-663513 </td><td>monoclonal antibody </td><td>therapeutic </td><td>CD137</td></tr>
<tr><td>vosaroxin </td><td>SNS-595 </td><td>small molecule </td><td>therapeutic</td><td>TOP2</td></tr>
</tbody></table></center><br />
<div></div><br />
As you will see there is a bumper crop this month of new USANs. Lots of monoclonal antibodies and kinase inhibitors (although these are seen as both the parent and salt for in many cases).</div></div>